New cinnamic acid-pregenolone hybrids as potential antiproliferative agents: design, synthesis and biological evaluation

Publication date: Available online 16 September 2019Source: SteroidsAuthor(s): Yong-Xi Ge, Yan-Hong Wang, Juan Zhang, Zhi-Pu Yu, Xin Mu, Jia-Li Song, Yin-Yin Wang, Feifei Yang, Ning Meng, Cheng-Shi Jiang, Hua ZhangAbstractA series of new cinnamic acid-pregenolone hybrids (5a-5o) was designed, synthesized and evaluated for their in vitro antiproliferative activity. Some of them showed potential antiproliferative activity and selectivity towards a panel of cancer cell lines, including A549, H157, HepG2, MCF-7, and HL-60. Among these analogs, compound 5f showed the most promising activity with IC50 values ranging from 3.2 to 6.8 μM, and it was taken as a model compound in the following antiproliferative mechanism study. In Hoechst 33258 staining assay, 5f-treated A549 cells displayed significant apoptosis characteristics. Flow cytometry analysis revealed that 5f showed the antiproliferative activity against A549 via G1 cell cycle arrest and inducing apoptosis. Western blotting analysis demonstrated that 5f enhanced apoptosis of A549 cells by down-regulating Bcl-2 and up-regulating Bax protein expression. The present study highlighted this series of cinnamic acid-pregenolone hybrids as a new antiproliferative lead prototype.Graphical abstract
Source: Steroids - Category: Drugs & Pharmacology Source Type: research